Mednow Inc.
MDNWF
$0.00
$0.000.00%
OTC PK
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 91.62% | 432.22% | 1,243.28% | 6,082.39% | 4,896.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 91.62% | 432.22% | 1,243.28% | 6,082.39% | 4,896.35% |
| Cost of Revenue | 111.06% | 475.31% | 1,799.88% | -- | -- |
| Gross Profit | 12.65% | 231.50% | 343.72% | 618.79% | 887.02% |
| SG&A Expenses | -33.16% | -26.79% | -4.77% | 36.28% | 83.97% |
| Depreciation & Amortization | 5.65% | 144.51% | 390.42% | 686.28% | 1,169.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.58% | 87.00% | 143.41% | 221.34% | 238.17% |
| Operating Income | 39.04% | 34.98% | 12.58% | -33.68% | -69.09% |
| Income Before Tax | 36.13% | 30.62% | 10.88% | -241.15% | -69.62% |
| Income Tax Expenses | 140.06% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.67% | 30.18% | 9.69% | -231.68% | -65.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.06% | 291.76% | 760.34% | -- | -- |
| Net Income | 33.74% | 30.79% | 10.86% | -232.44% | -65.33% |
| EBIT | 39.04% | 34.98% | 12.58% | -33.68% | -69.09% |
| EBITDA | 35.74% | 35.43% | 14.57% | -28.27% | -54.49% |
| EPS Basic | 33.74% | 30.81% | 10.86% | -233.96% | -51.79% |
| Normalized Basic EPS | 36.87% | 34.77% | 12.77% | -39.93% | -56.74% |
| EPS Diluted | 33.74% | 30.81% | 10.86% | -233.96% | -51.79% |
| Normalized Diluted EPS | 36.87% | 34.77% | 12.77% | -39.93% | -56.74% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | -0.46% | 8.91% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | -0.46% | 8.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |